M&T Bank’s bluebird bio BLUE Stock Holding History

M&T Bank’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-131	Closed	-$215K	–	1618
2019 Q2	$215K	Sell	131 -35	-21%	-$60.5K	﹤0.01%	1385
2019 Q1	$338K	Sell	166 -6	-3%	-$10.6K	﹤0.01%	1149
2018 Q4	$221K	Buy	+172	New	+$264K	﹤0.01%	1251
2015 Q4	–	Sell	-186	Closed	-$207K	–	1754
2015 Q3	$207K	Buy	+186	New	+$339K	﹤0.01%	1516
2015 Q2	–	Sell	-172	Closed	-$270K	–	2106
2015 Q1	$270K	Buy	+172	New	+$227K	﹤0.01%	1525

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

M&T Bank's BLUE Position: Q3 2019 in Review

M&T Bank sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 131 shares — an estimated $215K sold.

M&T Bank first reported a position in BLUE in Q1 2015 and held it in 5 quarters. The position peaked at $338K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

M&T Bank reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
M&T Bank sold 131 bluebird bio shares in Q3 2019, an estimated $215K.
M&T Bank first reported a position in bluebird bio in Q1 2015 and held it in 5 quarters.
M&T Bank's bluebird bio position peaked at $338K in Q1 2019.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on M&T Bank's 13F filing for Q3 2019, filed 12 Nov 2019.